Recent analysis
India Exports the Naphtha and Benzene Its Own Pharma Industry Needs — Mostly to China
India's naphtha exports to China doubled to $2.4bn in FY2025-26, the same fiscal year ethanol blending freed up the refinery capacit...
Read the piece →India's Semaglutide Patent Cliff: 26 Brands in Weeks, a Price War, and a Government Crackdown
Semaglutide's Indian patent expired on 20 March 2026; within weeks, 13 companies had launched 26 branded generics, Novo Nordisk cut ...
Read the piece →Five Years and ₹25,000 Crore Later, China Still Supplies Three-Quarters of India's Drug-Making Ingredients
What India's own government data says about the distance between how much active pharmaceutical ingredient the country consumes and ...
Read the piece →India's E-Commerce Inventory Ban Just Got Its First Real Exception — For Exports Only
Since 2018, India has flatly barred foreign-funded e-commerce companies from owning the inventory they sell to Indian consumers, through...
Read the piece →
Contact Us
Umashankar Triplicane Dwarakanathan
Investment Promotion & Energy-Sector Leader · Chennai, Tamil Nadu, India